{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T22:50:46Z","timestamp":1794523846202,"version":"4.9.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,2]],"date-time":"2020-10-02T00:00:00Z","timestamp":1601596800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.clinre.2020.09.002","type":"journal-article","created":{"date-parts":[[2020,10,26]],"date-time":"2020-10-26T19:00:03Z","timestamp":1603738803000},"page":"101535","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Drug-eluting bead transarterial chemoembolization is an effective downstaging option for subsequent radical treatments in patients with hepatocellular carcinoma: A cohort study"],"prefix":"10.1016","volume":"45","author":[{"given":"Liang","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honglu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenpeng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youjia","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaopu","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongliu","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xihong","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenying","family":"Diao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinre.2020.09.002_bib0005","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1067\/j.cpradiol.2015.04.004","article-title":"Hepatocellular carcinoma: review of epidemiology, screening, imaging diagnosis, response assessment, and treatment","volume":"44","author":"Clark","year":"2015","journal-title":"Curr Probl Diagn Radiol"},{"key":"10.1016\/j.clinre.2020.09.002_bib0010","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1586\/17474124.2015.1028363","article-title":"The evolving epidemiology of hepatocellular carcinoma: a global perspective","volume":"9","author":"Wallace","year":"2015","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2020.09.002_bib0015","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11864-020-0725-3","article-title":"Curative-intent therapies in localized hepatocellular carcinoma","volume":"21","author":"O\u2019Leary","year":"2020","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.clinre.2020.09.002_bib0020","doi-asserted-by":"crossref","first-page":"215","DOI":"10.21037\/jgo.2017.03.13","article-title":"Locoregional and systemic therapy for hepatocellular carcinoma","volume":"8","author":"Gbolahan","year":"2017","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.clinre.2020.09.002_bib0025","doi-asserted-by":"crossref","first-page":"106","DOI":"10.21037\/tgh.2017.11.18","article-title":"Downstaging for hepatocellular cancer: harm or benefit?","volume":"2","author":"Bryce","year":"2017","journal-title":"Transl Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2020.09.002_bib0030","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1097\/TP.0000000000000121","article-title":"Conventional TACE and drug-eluting bead TACE as locoregional therapy before orthotopic liver transplantation: comparison of explant pathologic response","volume":"98","author":"Frenette","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.clinre.2020.09.002_bib0035","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1148\/radiol.2019181991","article-title":"Radiofrequency ablation following downstaging of hepatocellular carcinoma by using transarterial chemoembolization: long-term outcomes","volume":"293","author":"Shi","year":"2019","journal-title":"Radiology"},{"key":"10.1016\/j.clinre.2020.09.002_bib0040","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1007\/s00330-019-06604-y","article-title":"Microwave ablation after downstaging of hepatocellular carcinoma: outcome was similar to tumor within Milan criteria","volume":"30","author":"Shi","year":"2020","journal-title":"Eur Radiol"},{"key":"10.1016\/j.clinre.2020.09.002_bib0045","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3748\/wjg.v24.i2.161","article-title":"Drug-eluting beads transarterial chemoembolization for hepatocellular carcinoma: current state of the art","volume":"24","author":"Facciorusso","year":"2018","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clinre.2020.09.002_bib0050","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1245\/s10434-007-9549-7","article-title":"Salvage surgery following downstaging of unresectable hepatocellular carcinoma--a strategy to increase resectability","volume":"14","author":"Lau","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clinre.2020.09.002_bib0055","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12957-018-1368-8","article-title":"CalliSpheres drug-eluting beads versus lipiodol transarterial chemoembolization in the treatment of hepatocellular carcinoma: a short-term efficacy and safety study","volume":"16","author":"Wu","year":"2018","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.clinre.2020.09.002_bib0060","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.2217\/fon-2018-0136","article-title":"DEB-TACE: a standard review","volume":"14","author":"Melchiorre","year":"2018","journal-title":"Future Oncol"},{"key":"10.1016\/j.clinre.2020.09.002_bib0065","article-title":"Drug-eluting bead transarterial chemoembolization (TACE) vs conventional TACE in treating hepatocellular carcinoma patients with multiple conventional TACE treatments history: A comparison of efficacy and safety","volume":"98","author":"Li","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clinre.2020.09.002_bib0070","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1159\/000488035","article-title":"Guidelines for diagnosis and treatment of primary liver cancer in China (2017 Edition)","volume":"7","author":"Zhou","year":"2018","journal-title":"Liver Cancer"},{"key":"10.1016\/j.clinre.2020.09.002_bib0075","doi-asserted-by":"crossref","first-page":"941","DOI":"10.2147\/CMAR.S187203","article-title":"Comparison of chemoembolization with CalliSpheres((R)) microspheres and conventional chemoembolization in the treatment of hepatocellular carcinoma: a multicenter retrospective study","volume":"12","author":"Liang","year":"2020","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.clinre.2020.09.002_bib0080","doi-asserted-by":"crossref","first-page":"5687","DOI":"10.3748\/wjg.v25.i37.5687","article-title":"Long-term outcomes of hepatocellular carcinoma that underwent chemoembolization for bridging or downstaging","volume":"25","author":"Affonso","year":"2019","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clinre.2020.09.002_bib0085","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1002\/lt.24169","article-title":"Downstaging hepatocellular carcinoma: a systematic review and pooled analysis","volume":"21","author":"Parikh","year":"2015","journal-title":"Liver Transpl"},{"key":"10.1016\/j.clinre.2020.09.002_bib0090","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.jhep.2009.12.032","article-title":"The place of downstaging for hepatocellular carcinoma","volume":"52","author":"Toso","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2020.09.002_bib0095","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1007\/s11604-014-0358-1","article-title":"Prognosis of patients with intermediate-stage hepatocellular carcinomas based on the Child-Pugh score: subclassifying the intermediate stage (Barcelona Clinic Liver Cancer stage B)","volume":"32","author":"Yamakado","year":"2014","journal-title":"Jpn J Radiol"},{"key":"10.1016\/j.clinre.2020.09.002_bib0100","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1200\/JCO.2014.57.9151","article-title":"Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade","volume":"33","author":"Johnson","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clinre.2020.09.002_bib0105","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.jhep.2016.10.038","article-title":"Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC","volume":"66","author":"Notarpaolo","year":"2017","journal-title":"J Hepatol"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740120302734?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740120302734?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:32:11Z","timestamp":1761895931000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740120302734"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S2210740120302734"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2020.09.002","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug-eluting bead transarterial chemoembolization is an effective downstaging option for subsequent radical treatments in patients with hepatocellular carcinoma: A cohort study","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2020.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"101535"}}